What The Trump Administration's Cannabis Reclassification Means For The Drug

The federal government has reclassified cannabis, moving it from Schedule I to Schedule III. This change means cannabis is now recognized as having accepted medical use, similar to Tylenol with codeine or steroids. Previously, Schedule I drugs like heroin and LSD were considered to have no accepted medical use. This reclassification is not a legalization of recreational cannabis, which remains a state-level issue. Instead, it specifically applies to medical-grade cannabis. Physicians can now treat patients with medical-grade cannabis sourced from licensed companies, and research into its benefits can be conducted. Additionally, companies operating in the medical cannabis sector will receive relief from certain tax burdens. Recreational use will continue to be managed by individual states, with further review from the DEA and DOJ after a 60-day public comment period. This move makes cannabis a regulated medical substance, but not yet a regulated consumer product.